Patents by Inventor Roger Warren Sands

Roger Warren Sands has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INJECTABLE PREFORMED MACROSCOPIC 3-DIMENSIONAL SCAFFOLDS FOR MINIMALLY INVASIVE ADMINISTRATION
    Publication number: 20230404936
    Abstract: The invention provides polymer compositions for cell and drug delivery.
    Type: Application
    Filed: January 10, 2023
    Publication date: December 21, 2023
    Applicant: President and Fellows of Harvard College
    Inventors: Sidi A. Bencherif, David J. Mooney, David Edwards, Roger Warren Sands
  • INJECTABLE CRYOGEL VACCINE DEVICES AND METHODS OF USE THEREOF
    Publication number: 20210205233
    Abstract: The invention provides polymer compositions for cell and drug delivery.
    Type: Application
    Filed: October 29, 2020
    Publication date: July 8, 2021
    Applicant: President and Fellows of Harvard College
    Inventors: Sidi A. Bencherif, Roger Warren Sands, Sandeep T. Koshy, David J. Mooney
  • PROGRAMMING OF CELLS FOR TOLEROGENIC THERAPIES
    Publication number: 20190183992
    Abstract: Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease.
    Type: Application
    Filed: September 5, 2018
    Publication date: June 20, 2019
    Inventors: Roger Warren Sands, Eduardo Alexandre Barros E Silva, Toshihisa Kawai, David J. Mooney
  • INJECTABLE PREFORMED MACROSCOPIC 3-DIMENSIONAL SCAFFOLDS FOR MINIMALLY INVASIVE ADMINISTRATION
    Publication number: 20190076373
    Abstract: The invention provides polymer compositions for cell and drug delivery.
    Type: Application
    Filed: July 11, 2018
    Publication date: March 14, 2019
    Inventors: Sidi A. Bencherif, David J. Mooney, David Edwards, Roger Warren Sands
  • Programming of cells for tolerogenic therapies
    Patent number: 10080789
    Abstract: Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease.
    Type: Grant
    Filed: May 5, 2016
    Date of Patent: September 25, 2018
    Assignees: President and Fellows of Harvard College, Forsyth Dental Infirmary for Children
    Inventors: Roger Warren Sands, Eduardo Alexandre Barros E Silva, Toshihisa Kawai, David J. Mooney
  • Injectable Cryogel Vaccine Devices and Methods of Use Thereof
    Publication number: 20180243231
    Abstract: The invention provides polymer compositions for cell and drug delivery.
    Type: Application
    Filed: June 8, 2017
    Publication date: August 30, 2018
    Inventors: Sidi A. Bencherif, Roger Warren Sands, Sandeep T. Koshy, David J. Mooney
  • Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
    Patent number: 10045947
    Abstract: The invention provides polymer compositions for cell and drug delivery.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: August 14, 2018
    Assignee: President and Fellows of Harvard College
    Inventors: Sidi A. Bencherif, David J. Mooney, David Edwards, Roger Warren Sands
  • IMMUNOCONJUGATES FOR PROGRAMMING OR REPROGRAMMING OF CELLS
    Publication number: 20180117171
    Abstract: The conjugate compositions and methods are useful to elicit/augment an immune response to a tumor or microbial infection or to reduce the severity of autoimmunity, chronic inflammation, allergy, asthma, periodontal disease, and transplant rejection.
    Type: Application
    Filed: April 1, 2016
    Publication date: May 3, 2018
    Inventors: David J. Mooney, Roger Warren Sands, Joel Stern, Aileen W. Li, Rajiv Desai, Beverly Ying Lu
  • Injectable cryogel vaccine devices and methods of use thereof
    Patent number: 9675561
    Abstract: The invention provides polymer compositions for cell and drug delivery.
    Type: Grant
    Filed: January 28, 2014
    Date of Patent: June 13, 2017
    Assignee: President and Fellows of Harvard College
    Inventors: Sidi A. Bencherif, Roger Warren Sands, Sandeep T. Koshy, David J. Mooney
  • Programming of Cells for Tolerogenic Therapies
    Publication number: 20160317630
    Abstract: Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease.
    Type: Application
    Filed: May 5, 2016
    Publication date: November 3, 2016
    Inventors: Roger Warren Sands, Eduardo Alexandre Barros E Silva, Toshihisa Kawai, David J. Mooney
  • Programming of cells for tolerogenic therapies
    Patent number: 9381235
    Abstract: Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease.
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: July 5, 2016
    Assignees: President and Fellows of Harvard College, Forsyth Dental Infirmary for Children
    Inventors: Roger Warren Sands, Eduardo Alexandre Barros e Silva, Toshihisa Kawai, David J. Mooney
  • PROGRAMMING OF CELLS FOR TOLEROGENIC THERAPIES
    Publication number: 20140234423
    Abstract: Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease.
    Type: Application
    Filed: February 20, 2014
    Publication date: August 21, 2014
    Applicants: FORSYTH DENTAL INFIRMARY FOR CHILDREN, PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Roger Warren Sands, Eduardo Alexandre Barros e Silva, Toshihisa Kawai, David J. Mooney
  • Injectable Cryogel Vaccine Devices and Methods of Use Thereof
    Publication number: 20140227327
    Abstract: The invention provides polymer compositions for cell and drug delivery.
    Type: Application
    Filed: January 28, 2014
    Publication date: August 14, 2014
    Inventors: Sidi A. Bencherif, Roger Warren Sands, Sandeep T. Koshy, David J. Mooney
  • Programming of cells for tolerogenic therapies
    Patent number: 8728456
    Abstract: Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: May 20, 2014
    Assignees: President and Fellows of Harvard College, Forsyth Dental Infirmary for Children
    Inventors: Roger Warren Sands, Eduardo Alexandra Barros e Silva, Toshihisa Kawai, David J. Mooney
  • Injectable Preformed Macroscopic 3-Dimensional Scaffolds for Minimally Invasive Administration
    Publication number: 20140112990
    Abstract: The invention provides polymer compositions for cell and drug delivery.
    Type: Application
    Filed: April 27, 2012
    Publication date: April 24, 2014
    Applicant: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Sidi A. Bencherif, David J. Mooney, David Edwards, Roger Warren Sands
  • Programming Of Cells for Tolerogenic Therapies
    Publication number: 20120121539
    Abstract: Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease.
    Type: Application
    Filed: August 2, 2010
    Publication date: May 17, 2012
    Applicant: President and Fellows of Harvard College
    Inventors: Roger Warren Sands, Eduardo Alexandre Barros e Silva, Toshihisa Kawai, David J. Mooney